Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells - Ultragenyx Pharmaceutical (NASDAQ:RARE)

Card image cap

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical over the use of HeLa cells taken without her consent in the 1950s. A Maryland federal court ruled against Ultragenyx's motion to dismiss, allowing the case to continue.

Related Keywords

Maryland , United States , Baltimore , Christopher Ayers , Henrietta Lacks , Seeger Weiss , Deborah Boardman , Christopher Seeger , Reuters , Thermo Fisher , Judge Boardman , Thermo Fisher Scientificinc ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.